Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(18):1490-1499; doi:10.1093/jnci/92.18.1490
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Miller, A. B.
Right arrow Articles by Wall, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, A. B.
Right arrow Articles by Wall, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 18, 1490-1499, September 20, 2000
© 2000 Oxford University Press

Canadian National Breast Screening Study-2: 13-Year Results of a Randomized Trial in Women Aged 50–59 Years

Anthony B. Miller, Teresa To, Cornelia J. Baines, Claus Wall, For the Canadian National Breast Screening Study-2

Affiliations of authors: A. B. Miller, C. J. Baines, Department of Public Health Sciences, University of Toronto, Canada; T. To, Department of Public Health Sciences, University of Toronto, and Population Health Sciences, The Hospital for Sick Children, Toronto; C. Wall, Institute for Clinical Evaluative Sciences in Ontario, Toronto.

Correspondence to: Anthony B. Miller, M.B., F.R.C.P., Division of Clinical Epidemiology, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany (e-mail: A.Miller{at}DKFZ-Heidelberg.de).

Background: Screening for breast cancer with mammography in women aged 50 years or more has been shown to reduce mortality from breast cancer. However, the extent to which mammography contributes to the reduction of mortality in women who also undergo physical examination of the breasts is not known. This study was designed to compare breast cancer mortality following annual screening consisting of two-view mammography and physical examination of the breasts with mortality following annual screening by physical examination only. Breast self-examination was taught to all participants. Methods: This trial randomly and individually assigned 39 405 women aged 50–59 years, recruited from January 1980 through March 1985, to one of the study arms. The women were followed by record linkage with the Canadian National Cancer Registry and National Mortality Database to December 31, 1993, and by active follow-up of breast cancer patients to June 30, 1996. Results: Randomization achieved virtually equal distribution of demographic and breast cancer risk variables. At the first annual screen, 21% of the cancers found by mammography alone (in the mammography plus physical examination group) were 20 mm or more in size compared with 46% of those found by physical examination in the mammography plus physical examination group and 56% in the physical examination-only group. The corresponding percentages for screens 2–5 were 10%, 42%, and 50%, respectively. Screening detected 267 invasive breast cancers in the mammography plus physical examination group compared with 148 in the physical examination-only group. By December 31, 1993, 622 invasive and 71 in situ breast carcinomas were ascertained in the mammography plus physical examination group, and 610 and 16 were ascertained in the physical examination-only group. At 13-year follow-up, with 107 and 105 deaths from breast cancer in the respective groups, the cumulative rate ratio was 1.02 (95% confidence interval = 0.78–1.33). Conclusion: In women aged 50–59 years, the addition of annual mammography screening to physical examination has no impact on breast cancer mortality.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
H. G. Welch, S. Woloshin, and L. M. Schwartz
The Sea of Uncertainty Surrounding Ductal Carcinoma In Situ--The Price of Screening Mammography
J Natl Cancer Inst, February 20, 2008; 100(4): 228 - 229.
[Full Text] [PDF]


Home page
RadiologyHome page
R. L. Ellis, A. A. Meade, M. A. Mathiason, K. M. Willison, and W. Logan-Young
Evaluation of Computer-aided Detection Systems in the Detection of Small Invasive Breast Carcinoma
Radiology, October 1, 2007; 245(1): 88 - 94.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
B. Devi, T. Tang, and M Corbex
Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia
Ann. Onc., July 1, 2007; 18(7): 1172 - 1176.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
S. Y. G. L. Tan, G. J. van Oortmarssen, H. J. de Koning, R. Boer, and J. D. F. Habbema
Chapter 9: The MISCAN-Fadia Continuous Tumor Growth Model for Breast Cancer
J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 56 - 65.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
L. D. Clarke, S. K. Plevritis, R. Boer, K. A. Cronin, and E. J. Feuer
Chapter 13: A Comparative Review of CISNET Breast Models Used To Analyze U.S. Breast Cancer Incidence and Mortality Trends
J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 96 - 105.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. G. Elmore, N. S. Weiss, W. E. Barlow, S. W. Fletcher, L. M. Reisch, M. B. Barton, S. J. Rolnick, S. M. Greene, and G. Hart
RESPONSE: Re: Efficacy of Breast Cancer Screening in the Community According to Risk Level
J Natl Cancer Inst, November 16, 2005; 97(22): 1704 - 1705.
[Full Text] [PDF]


Home page
NEJMHome page
D. A. Berry, K. A. Cronin, S. K. Plevritis, D. G. Fryback, L. Clarke, M. Zelen, J. S. Mandelblatt, A. Y. Yakovlev, J. D. F. Habbema, E. J. Feuer, et al.
Effect of screening and adjuvant therapy on mortality from breast cancer.
N. Engl. J. Med., October 27, 2005; 353(17): 1784 - 1792.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
Y. Shen, Y. Yang, L. Y. T. Inoue, M. F. Munsell, A. B. Miller, and D. A. Berry
Role of Detection Method in Predicting Breast Cancer Survival: Analysis of Randomized Screening Trials
J Natl Cancer Inst, August 17, 2005; 97(16): 1195 - 1203.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. G. Elmore, K. Armstrong, C. D. Lehman, and S. W. Fletcher
Screening for Breast Cancer
JAMA, March 9, 2005; 293(10): 1245 - 1256.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S. A. Khan, E. L. Wiley, N. Rodriguez, C. Baird, R. Ramakrishnan, R. Nayar, M. Bryk, K. B. Bethke, V. L. Staradub, J. Wolfman, et al.
Ductal Lavage Findings in Women With Known Breast Cancer Undergoing Mastectomy
J Natl Cancer Inst, October 20, 2004; 96(20): 1510 - 1517.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
G. D. Leonard and S. M. Swain
Ductal Carcinoma In Situ, Complexities and Challenges
J Natl Cancer Inst, June 16, 2004; 96(12): 906 - 920.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
D. A Freedman, D. B Petitti, and J. M Robins
On the efficacy of screening for breast cancer
Int. J. Epidemiol., February 1, 2004; 33(1): 43 - 55.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
A. B Miller
Commentary: A defence of the Health Insurance Plan (HIP) study and the Canadian National Breast Screening Study (CNBSS)
Int. J. Epidemiol., February 1, 2004; 33(1): 64 - 65.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
C. J. Baines
Mammography Screening: Are Women Really Giving Informed Consent?
J Natl Cancer Inst, October 15, 2003; 95(20): 1508 - 1511.
[Full Text] [PDF]


Home page
CA Cancer J ClinHome page
R. A. Smith, D. Saslow, K. Andrews Sawyer, W. Burke, M. E. Costanza, W. P. Evans III, R. S. Foster Jr., E. Hendrick, H. J. Eyre, and S. Sener
American Cancer Society Guidelines for Breast Cancer Screening: Update 2003
CA Cancer J Clin, May 1, 2003; 53(3): 141 - 169.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
G. Pichert, B. Bolliger, K. Buser, and O. Pagani
Evidence-based management options for women at increased breast/ovarian cancer risk
Ann. Onc., January 1, 2003; 14(1): 9 - 19.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
A. C. ROQUE and T. C.S.S. ANDRE
Mammography and Computerized Decision Systems: A Review
Ann. N.Y. Acad. Sci., December 1, 2002; 980(1): 83 - 94.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
D G R Evans and F Lalloo
Risk assessment and management of high risk familial breast cancer
J. Med. Genet., December 1, 2002; 39(12): 865 - 871.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Public HealthHome page
G. M. Leung, T.-H. Lam, T. Q. Thach, and A. J. Hedley
Will Screening Mammography in the East Do More Harm than Good?
Am J Public Health, November 1, 2002; 92(11): 1841 - 1846.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
V. L. Ernster, R. Ballard-Barbash, W. E. Barlow, Y. Zheng, D. L. Weaver, G. Cutter, B. C. Yankaskas, R. Rosenberg, P. A. Carney, K. Kerlikowske, et al.
Detection of Ductal Carcinoma In Situ in Women Undergoing Screening Mammography
J Natl Cancer Inst, October 16, 2002; 94(20): 1546 - 1554.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
R. Harris and L. S. Kinsinger
Routinely Teaching Breast Self-Examination is Dead. What Does This Mean?
J Natl Cancer Inst, October 2, 2002; 94(19): 1420 - 1421.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
A. B. Miller, T. To, C. J. Baines, and C. Wall
The Canadian National Breast Screening Study-1: Breast Cancer Mortality after 11 to 16 Years of Follow-up: A Randomized Screening Trial of Mammography in Women Age 40 to 49 Years
Ann Intern Med, September 3, 2002; 137(5_Part_1): 305 - 312.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. L. Humphrey, M. Helfand, B. K.S. Chan, and S. H. Woolf
Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force
Ann Intern Med, September 3, 2002; 137(5_Part_1): 347 - 360.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
L. M. Schwartz and S. Woloshin
News Media Coverage of Screening Mammography for Women in Their 40s and Tamoxifen for Primary Prevention of Breast Cancer
JAMA, June 19, 2002; 287(23): 3136 - 3142.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
C. B. Begg
The Mammography Controversy
Oncologist, June 1, 2002; 7(3): 174 - 176.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. A. Feig
Image Quality of Screening Mammography: Effect on Clinical Outcome
Am. J. Roentgenol., April 1, 2002; 178(4): 805 - 807.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
W. C. Black, D. A. Haggstrom, and H. Gilbert Welch
All-Cause Mortality in Randomized Trials of Cancer Screening
J Natl Cancer Inst, February 6, 2002; 94(3): 167 - 173.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
T. J. Clifford, M. Sampson, and H. M. Schachter
Breast self-examination
Can. Med. Assoc. J., January 1, 2002; 166(2): 164 - 164.
[Full Text]


Home page
CMAJHome page
N. Baxter
Breast self-examination
Can. Med. Assoc. J., January 1, 2002; 166(2): 166 - 168.
[Full Text]


Home page
Am. J. Roentgenol.Home page
L. Berlin
Dot Size, Lead Time, Fallibility, and Impact on Survival: Continuing Controversies in Mammography
Am. J. Roentgenol., May 1, 2001; 176(5): 1123 - 1130.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
L. Berlin
The Missed Breast Cancer Redux: Time for Educating the Public About the Limitations of Mammography?
Am. J. Roentgenol., May 1, 2001; 176(5): 1131 - 1134.
[Full Text] [PDF]


Home page
BMJHome page
C J M de Wolf, G Q. della Rovere, R. Warren, A B Miller, and C J Baines
Detection of breast cancer
BMJ, March 31, 2001; 322(7289): 792a - 792.
[Full Text]


Home page
JNCI J Natl Cancer InstHome page
S. A. Narod
Re: Canadian National Breast Screening Study-2: 13-Year Results of a Randomized Trial in Women Aged 50-59 Years
J Natl Cancer Inst, March 7, 2001; 93(5): 396 - 396.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. B. Miller, C. J. Baines, and C. Wall
RESPONSE: Re: Canadian National Breast Screening Study-2: 13-Year Results of a Randomized Trial in Women Aged 50-59 Years
J Natl Cancer Inst, March 7, 2001; 93(5): 396a - 397a.
[Full Text] [PDF]


Home page
BMJHome page
A. B Miller, S. Rozenberg, B. Carly, F. Liebens, H. Ham, M. Baum, and J S Tobias
Effect of screening programme on mortality from breast cancer
BMJ, December 16, 2000; 321(7275): 1527a - 1527.
[Full Text]


Home page
BMJHome page
I. Mittra, M. Baum, H. Thornton, and J. Houghton
Is clinical breast examination an acceptable alternative to mammographic screening?
BMJ, October 28, 2000; 321(7268): 1071 - 1073.
[Full Text]


Home page
JWatch GeneralHome page
A Controversial Mammography Study Resurfaces
Journal Watch (General), October 6, 2000; 2000(1006): 1 - 1.
[Full Text]


Home page
CMAJHome page
A. B. Miller
Organized breast cancer screening programs in Canada
Can. Med. Assoc. J., October 1, 2000; 163(9): 1150 - 1151.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.